Coronavirus channel feed

Sanofi turns to an up­start in the mR­NA field in lat­est at­tempt to quick­ly squelch a glob­al pan­dem­ic

6 years ago
R&D

Ver­tex joins Mer­ck, Pfiz­er — re­vamp­ing multi­bil­lion-dol­lar tri­al strat­e­gy as biotech R&D crum­bles

6 years ago
R&D

Pfiz­er, My­lan deal takes a coro­n­avirus hit

6 years ago
Deals

EMA of­fers method­olog­i­cal con­sid­er­a­tions for tri­als dur­ing Covid-19 pan­dem­ic

6 years ago
FDA+

Covid-19 roundup: In­ter­cept, blue­bird and a grow­ing list of biotechs feel the pain as pan­dem­ic man­gles FDA, R&D sched­ules

6 years ago

Af­ter crit­ics lam­bast­ed Gilead for grab­bing the FDA's spe­cial rare drug sta­tus on remde­sivir, they're giv­ing it back

6 years ago
Pharma
FDA+

Covid-19 roundup: Bris­tol My­ers sus­pends clin­i­cal tri­als, grounds field team; Vir ush­ers an­ti­body can­di­dates to hu­man test­ing

6 years ago

FDA is­sues an­oth­er safe­ty alert re­lat­ed to fe­cal trans­plants, as da­ta sug­gest coro­n­avirus lingers in poop

6 years ago
FDA+

Mod­er­na CEO Stéphane Ban­cel out­lines a short path for emer­gency use of a coro­n­avirus vac­cine

6 years ago

FDA opens door to emer­gency use of con­va­les­cent plas­ma from re­cov­ered Covid-19 pa­tients

6 years ago

Covid-19 roundup: Where is Dr. Fau­ci?; AS­CO goes vir­tu­al

6 years ago

'I have a feel­ing': Trump-en­dorsed malar­ia drug fails to pass muster in small Chi­nese coro­n­avirus study

6 years ago

Caught in a Covid-19 mael­strom, Eli Lil­ly locks down clin­i­cal tri­als as multi­bil­lion-dol­lar R&D ops de­rail

6 years ago
R&D

Covid-19 roundup: FDA stamps quick OK on Roche's Actem­ra PhI­II; AlloVir ex­pands Bay­lor pact

6 years ago

In­un­dat­ed by de­mand, Gilead halts in­di­vid­ual emer­gency ac­cess to ex­per­i­men­tal Covid-19 drug

6 years ago

Covid-19 roundup: Italy death toll of­fi­cial­ly tops Chi­na; US com­pa­ny plans roll out of at-home spec­i­men col­lec­tion kits

6 years ago

FDA re­vamps ad­verse event re­port­ing guid­ance for Covid-19

6 years ago

No, Mr. Pres­i­dent, you can’t just or­der up out­break meds with the snap of your fin­gers

6 years ago
Bioregnum
Opinion

Bio­gen fires staffer who fled to Chi­na af­ter she was in­fect­ed in the biotech’s coro­n­avirus out­break

6 years ago

Drug­mak­er re­thinks its de­ci­sion to dou­ble price of a gener­ic af­ter Trump calls it a coro­n­avirus life­saver — re­ports

6 years ago

A trop­i­cal dis­ease doc­tor turns his sights on the coro­n­avirus

6 years ago
R&D

FDA un­veils guid­ance for Covid-19 tri­als

6 years ago
FDA+

Do­ing deals in a time of coro­n­avirus: Biotech CEO Bill Haney says 'y­ou fo­cus on the things that make a dif­fer­ence'

6 years ago
People
Deals

New da­ta from ran­dom­ized tri­al dent HIV drug strat­e­gy against Covid-19

6 years ago
R&D
First page Previous page 55565758596061 Next page Last page
A service from the Financial Times